Analysis

Clorox: Holding Pattern as Price Nudges Past Fair Value

By stockpickr AI | March 1, 2026 | 10 min read

Investment Summary

The Clorox Company (CLX), a staple in the Consumer Staples sector, appears slightly overvalued based on the DCF analysis compared to its current trading price.

Investment Recommendation

Hold

Fair Value: $134.55

Current Price: $139.99

Upside/Downside: -3.88%

The DCF valuation suggests a fair value slightly below the current market price. While the company offers stability and a dividend, the projected growth rates necessary to justify the premium P/E are aggressive given recent revenue trends, resulting in a neutral recommendation.

Key Metrics

  • Market Cap: $21.50B
  • P/E Ratio: 25.12x
  • Forward P/E: 21.22x
  • Revenue Growth (YoY): -1.0%
  • Net Margin: 8.1%
  • ROE: 34.2%
  • Debt/Equity: 2.01
  • Dividend Yield: 3.20%

Strengths

  • Dominant brand portfolio with high household penetration (e.g., Clorox brand market share above 70% in US bleach segment)
  • Consistent dividend history, having increased payments for over 10 consecutive years, appealing to income investors.
  • Relatively low Beta (0.46), indicating resilience during broader market volatility.
  • Strong Return on Equity (ROE) of 34.2%, signaling efficient use of shareholder capital, albeit potentially inflated by high leverage.

Risk Factors

  • High Debt-to-Equity ratio of 2.01, increasing financial risk amid rising interest rates.
  • Recent revenue contraction (-1.0% YoY), indicating softness in consumer demand or competitive pressures.
  • Exposure to fluctuating input costs (chemicals, packaging) that can compress gross margins.